| Product No | EMEA/H/C/000464 |
|---|---|
| Brand Name | Yondelis |
| Nonproprietary Name | trabectedin |
| API | trabectedin |
| ATC Code | L01CX01 |
| Indications | Yondelis is indicated for the treatment of patients with advanced soft tissue sarcoma, having failed antracyclines and ifosfamide, or having failed ifosfamide and unsuitable to receive antracyclines/ifosfamide. |
| Orphan Drug | no |
| Generics | no |
| Marketing Authorization Holder | Pharma Mar S.A. |
| Status | Refused(拒绝) |
| Authorization Date | 0000-00-00 |
| Version | 0 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information